EUVIMEDEUVIMED entdecken
Crossref

Development and Implementation of Oral Anticancer Agent Tools for a Thematic Quality Improvement Program: A Collaboration Between Hematology Oncology Pharmacist Association and ASCO Quality Training Program

Victoria Nachar iD, Marjorie Adams Curry iD, Diana Kostoff iD, Angela Wood, Karen B Farris iD, Benyam Muluneh iD, Amy Morris, Michael Keng iD, Vedner Guerrier iD, Emily R Mackler iD

JCO Oncology Practice · 2025

DOI: 10.1200/op-24-00475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2025. Verfasst von Victoria Nachar und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan Rogel Cancer Center, Ann Arbor, MI. Hauptthemen laut MEDLINE: Quality Improvement, Antineoplastic Agents, Pharmacists, Medical Oncology. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE The Hematology Oncology Pharmacist Association Oral Chemotherapy Collaborative (HOPA OCC) developed practice-based tools to use in program development and improvement for the management of patients receiving oral anticancer agents (OAAs). METHODS These tools include a baseline OAA program assessment, clinical OAA adherence tool, and OAA dashboard. HOPA OCC distributed these tools to teams participating in the 6-month HOPA ASCO Quality Training Programs (QTPs). Barriers in the delivery of OAA services across practice sites were determined through the use of baseline assessments, and the following domains were evaluated: (1) side-effect monitoring, (2) adherence monitoring, (3) use of patient-reported outcomes, (4) social determinants of health, and (5) collaborative practice agreements for oncology pharmacists. The OAA adherence tool offers clinical patient adherence questions and guidance for supporting adherence in practice. Finally, the dashboard includes multiple metrics that may be helpful for practices to measure their program outcomes. HOPA OCC used the Consolidated Framework for Implementation Research to assess tool usefulness by the QTP participants. RESULTS Barriers to implementation include deficits in information technology, resources, and competing priorities. CONCLUSION Standardized OAA tools can inform and support quality improvement initiatives and improve the care of patients receiving OAAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality ImprovementAntineoplastic AgentsPharmacistsMedical OncologyHumansAdministration, OralHematology

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • University of Michigan College of Pharmacy, Ann Arbor, MI.
  • Grady Health System, Atlanta, GA.
  • Henry Ford Hospital, Detroit, MI.
  • Trellis Rx, Robbinsdale, MN.
  • Michigan Oncology Quality Consortium and Michigan Institute for Care Management and Transformation, Ann Arbor, MI.

ORCID-Profile: Victoria Nachar, Marjorie Adams Curry, Diana Kostoff, Karen B Farris, Benyam Muluneh, Michael Keng, Vedner Guerrier, Emily R Mackler

Zitieren

APA

Nachar, V., Adams Curry, M., Kostoff, D., Wood, A., Farris, K. B., Muluneh, B., Morris, A., Keng, M., Guerrier, V., & Mackler, E. R. (2025). Development and Implementation of Oral Anticancer Agent Tools for a Thematic Quality Improvement Program: A Collaboration Between Hematology Oncology Pharmacist Association and ASCO Quality Training Program. JCO Oncology Practice. https://doi.org/10.1200/op-24-00475

Vancouver

Nachar V, Adams Curry M, Kostoff D, Wood A, Farris KB, Muluneh B, et al. Development and Implementation of Oral Anticancer Agent Tools for a Thematic Quality Improvement Program: A Collaboration Between Hematology Oncology Pharmacist Association and ASCO Quality Training Program. JCO Oncology Practice. 2025. doi:10.1200/op-24-00475

BibTeX
@article{Nachar2025,
  author = {Nachar, Victoria and Adams Curry, Marjorie and Kostoff, Diana and Wood, Angela and Farris, Karen B and Muluneh, Benyam and Morris, Amy and Keng, Michael and Guerrier, Vedner and Mackler, Emily R},
  title = {Development and Implementation of Oral Anticancer Agent Tools for a Thematic Quality Improvement Program: A Collaboration Between Hematology Oncology Pharmacist Association and ASCO Quality Training Program},
  journal = {JCO Oncology Practice},
  year = {2025},
  doi = {10.1200/op-24-00475}
}
Kostenlos starten →